Answers are grounded in this paper and cite their sources.
Observational study assesses inebilizumab efficacy as salvage therapy in acute NMOSD-ON, suggesting a role in treatment strategy.
To assess the efficacy and safety of inebilizumab as a salvage therapy for acute NMOSD-ON when corticosteroids fail, and explore its potential as a first-line treatment.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: